How to overcome resistance to new compounds in CLL
Side effects of idelalisib in CLL and how to manage them
Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps